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Abstract
Background: Dengue is an acute febrile illness caused by an arbovirus that is endemic in more than 100 countries.
Early diagnosis and adequate management are critical to reduce mortality. This study aims to identify clinical and
hematological features that could be useful to discriminate dengue from other febrile illnesses (OFI) up to the third
day of disease.
Methods: We conducted a sectional diagnostic study with patients aged 12 years or older who reported fever
lasting up to three days, without any evident focus of infection, attending an outpatient clinic in the city of Rio de
Janeiro, Brazil, between the years 2005 and 2008. Logistic regression analysis was used to identify symptoms,
physical signs, and hematological features valid for dengue diagnosis. Receiver-operating characteristic (ROC) curve
analyses were used to define the best cut-off and to compare the accuracy of generated models with the World
Health Organization (WHO) criteria for probable dengue.
Results: Based on serological tests and virus genome detection by polymerase chain reaction (PCR), 69 patients
were classified as dengue and 73 as non-dengue. Among clinical features, conjunctival redness and history of rash
were independent predictors of dengue infection. A model including clinical and laboratory features (conjunctival
redness and leukocyte counts) achieved a sensitivity of 81% and specificity of 71% and showed greater accuracy
than the WHO criteria for probable dengue.
Conclusions: We constructed a predictive model for early dengue diagnosis that was moderately accurate and
performed better than the current WHO criteria for suspected dengue. Validation of this model in larger samples
and in other sites should be attempted before it can be applied in endemic areas.
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Background
Dengue is an acute febrile illness caused by an arbovirus
(arthropod-borne virus) transmitted mainly by Aedes
aegypti mosquitoes. Four dengue virus serotypes
(DENV-1 to 4) are recognized and a primary infection
by one serotype does not provide immunity against the
others [1]. Nowadays, dengue is a global public health
problem. It is endemic in more than 100 countries
where 50 to 100 million infections are estimated to
occur each year [2].
In the region of Americas, Brazil alone accounted for
more than 60% of reported cases from 2000 to 2007,
when epidemics occurred in different regions of the
country related to the co-circulation of DENV-1, DENV-2,
and DENV-3 [3]. The state of Rio de Janeiro was the site
of introduction and later dissemination of these serotypes
after epidemics in the years 1986, 1990, and 2002 [4]. In
2007/2008, DENV-2 was reintroduced in this state and
caused an epidemic with more severe clinical presenta-
tions and more fatalities than previous ones, primarily
among children and adolescents [3]. Recently, DENV-4
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reemerged in the country, being identified in the state of
Rio de Janeiro in 2011 [5].
Clinical presentation of dengue fever varies along a
wide spectrum of signs and symptoms. Typically, it pre-
sents as a self-limiting disease characterized by fever
associated with symptoms such as headache, nausea,
vomiting, arthralgia, myalgia and/or rash. However, dur-
ing the course of the disease, some patients develop se-
vere manifestations related to increased vascular
permeability and plasma leakage that can lead to death.
Signs of spontaneous bleeding may be present and are
more frequent in severe forms [6]. There is no specific
therapy, but timely initiated supportive treatment can re-
duce the lethality of severe cases to less than 1% [7].
Early identification of dengue infection could help
clinicians to institute adequate case management and to
identify patients who should be closely monitored for
signs of plasma leakage. This information might pro-
mote early supportive therapies [8], prevent the use of
potentially harmful drugs [9] and encourage assessment
of prognosis and the use of treatment guidelines [10].
Despite the recent development of rapid laboratory
tests [11-13], their availability is still limited and most
diagnoses in endemic areas are based on clinical and
epidemiological criteria. Until 2006, most studies on
clinical features to discriminate dengue from other fe-
brile illnesses have evaluated hospitalized patients in
Southeast Asia [14]. Despite some evidence that clinical
signs and symptoms vary during the course of the dis-
ease, few of those studies reported disease duration at
the time of clinical evaluation. Therefore, comparison of
results and identification of useful features for early
diagnosis was difficult [14].
In recent years, the focus on early clinical predictors
[15,16] and the use of regression methods to evaluate
multiple predictors has increased [15-17]. Some studies
using these methods were also done in the Americas
[18-21]. In Brazil, although some studies have identified
signs and symptoms associated with confirmed dengue
cases [22,23], the evaluation of multiple clinical criteria
with the aim of constructing a diagnostic algorithm has
not yet been attempted.
This study aims to: 1) identify clinical and laboratory
features useful for discriminating dengue from other fe-
brile illnesses (OFI) in the first three days of disease; and




A sectional diagnostic study was conducted with data
that were systematically collected at the outpatient clinic
for Acute Febrile Illnesses (AFI) of a public research in-
stitute from January 2005 to July 2008. Data collected
once a week by the same staff in the Emergency Depart-
ment (ED) of a public general hospital from November
2007 to January 2008 were also included. Patients older
than 12 years of age who presented with a history of
fever lasting up to three days without an evident or sus-
pected focus on clinical examination (such as tonsillitis
or pyelonephritis) were eligible to be included in the
study. Those with severely compromised health status (i.
e. with altered consciousness, signs of shock or severely
dehydrated) in need of emergency care were excluded.
Enrollment was sequential at the outpatient clinic, four
afternoons a week. At the emergency department, once
a week the research team evaluated the first eight eli-
gible patients who attended the ED. Both health units
are located in the city of Rio de Janeiro and the research
institute does not provide pediatric care. Although den-
gue fever is considered endemic in Rio de Janeiro, from
November 2007 to April 2008 a DEN-2 epidemic was
also detected in the city.
Collection of patient data
Attending staff included two infectious disease specia-
lists and two supervised medical students. All were
trained to perform and record standardized clinical eva-
luations and fill a form containing 28 symptoms and 25
signs potentially useful in the differential diagnosis of fe-
brile illnesses, according to literature review and specia-
lists consensus. Interobserver agreement on signs and
symptoms was evaluated in a subsample of 140 patients
and was almost perfect (kappa > 0.80) for most collected
clinical data [24]. The questionnaire is available online
for consultation and details on its development have
been described elsewhere [24].
On initial presentation, patients were evaluated
through comprehensive clinical history taking and phys-
ical examination. Clinical data were recorded on the
standardized form and blood samples were collected for
a complete blood count and dengue diagnostic tests. A
second sample was requested for all patients 7–10 days
after the initial visit for paired serology. Additional la-
boratory tests were done according to individual clinical
judgment.
The study was approved by the IPEC-FIOCRUZ Ethics
Committee and all the patients and/or their guardians
agreed to participate by providing a written informed
consent.
Variable definitions
Clinical variables investigated were standardized accord-
ing to clear definitions described in the research proto-
col and included the following: hepatomegaly – liver size
of 12 cm or more at percussion; lymph node enlarge-
ment – presence of one or more lymph nodes measuring
1 cm or more at palpation; pallor – any degree of skin
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or mucosa paleness; dehydration – dry mucosa at in-
spection; and splenomegaly – a palpable spleen at inspir-
ation with the patient lying on his right side. Taste
disorder was considered present when patients answered
affirmatively to the question “Does food or water taste
differently?”
Laboratory methods
Acute and convalescent serum samples were tested for
anti-dengue immunoglobulin M (IgM). Blood samples
collected up to the fifth febrile day were also screened
for viral RNA using reverse-transcriptase polymerase
chain reaction (RT-PCR) and/or tested for NS1 antigen.
Light microscopy of thick stained blood smears for
intracellular malarial parasites was performed in acute
blood samples from patients who had been in malaria
endemic regions.
Tests for IgM detection were done using an IgM
antibody-capture enzyme-linked immunosorbent assay
(MAC-ELISA) (PanBio, Brisbane, Australia) according to
the manufacturer’s instructions. Dengue NS1 antigen
was detected with the Platelia™ Dengue NS1Ag-ELISA
(Bio-Rad Laboratories Marnes-la-Coquette, France).
Both tests were performed at the Laboratory of Immu-
nodiagnostics at IPEC-FIOCRUZ. RNA detection was
performed in the Laboratory of Flavivirus, Oswaldo
Cruz Institute (FIOCRUZ) using RT-PCR according
to Lanciotti et al. [25].
Case definitions
Dengue diagnosis was based on the combination of dif-
ferent tests, considering their accuracy in different dis-
ease phases [1,26-28]. Stating as day 0 the day of fever
onset, we classified patients as:
Dengue (D): A patient who tests positive for either
IgM antibodies, viral RNA (RT-PCR) or NS1 antigen;
Non-Dengue (ND): A patient who tests negative for
anti-dengue IgM antibodies in a sample collected be-
tween day 7 and day 21 OR a patient with a unique sam-
ple collected between day 0 and day 2 that is negative
for both NS1 antigen and anti-dengue IgM;
Indeterminate: A patient who is negative for IgM anti-
bodies and NS1 antigen in an acute sample collected
after day 2 for whom a convalescent sample is not
available.
Statistical analysis
We carried out an exploratory analysis of clinical and la-
boratory features comparing D and ND groups. We used
Pearson Chi-square or Fisher’s exact test for categorical
and Mann-Whitney test for continuous variables, con-
sidering a level of significance of 0.05. Variables that
were significant in the exploratory analysis were selected
for inclusion in a multiple logistic regression model. The
two estimated models included: a) clinical data only, and
b) clinical and laboratory data.
Logistic regression parameters were estimated with the
Firth procedure that uses the penalized likelihood func-
tion [29]. This method enables estimation of parameters
in small samples with strongly predictive covariates,
where the phenomenon of separation makes at least one
parameter estimate diverge to ± infinity. A manual step-
wise backward selection approach was used, considering
as the criterion for maintaining variables in the model a
p-value of less than 0.05 on the penalized log-likelihood
ratio test.
For the regression model including laboratory data, a
receiver-operating characteristic (ROC) curve was plot-
ted. The best cut-off value for probabilities was deter-
mined by the Youden index that maximizes the sum of
sensitivity and specificity. Subsequently, these values
were substituted in the model’s equation and the combi-
nations of variable values that classified a patient as a
dengue case were determined.
We also evaluated the predictive accuracy of the
WHO criteria for probable dengue, which states that at
least two of the following manifestations must be
present in an acute febrile patient: headache, retro-
orbital pain, myalgia, arthralgia, exanthema, leukopenia,
and hemorrhagic manifestations [30]. For each patient,
we computed the number of these manifestations (from
zero to seven) that were present. We defined leukopenia
as a leukocyte count lower than 4,000/mm3.
With the aim of ascertaining the best predictive model,
ROC curve analysis was also done for WHO criteria and
the difference between the areas under the curves
(AUC) of the curves’ pair (estimated model x WHO cri-
teria) was tested by Delong’s method [31]. Confidence
intervals (CI) for the AUC, sensitivities and specificities
were estimated using pROC package functions which
compute the 95% CI with 2000 stratified bootstrap repli-
cates (with replacement) [32]. Data collected in forms
were entered using Epidata 3.1 software [33]. Explora-
tory analyses were done with Statistical Package for So-
cial Sciences - SPSS v. 17.0 (SPSS Inc., Chicago, Illinois).
Logistic regression with Firth correction was implemen-
ted with logistf package [34] and ROC curve analyses
with pROC package [32] from the R 2.11.1 software [35].
Results
From a total of 182 evaluated patients, 40 (22.0%) were
excluded from analyses as their diagnoses were indeter-
minate. From the remaining 142 patients, 69 were classi-
fied as dengue (D) and 73 as non-dengue (ND). Median
age and distribution by health units were not different
between D and ND patients. Male sex was predominant
(65.2%) among dengue cases, but was not among non-
dengue patients (47.9%). The majority of dengue cases
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(71%) were enrolled in the epidemic period (Table 1).
DENV-3 was the unique identified serotype in the first
years of the study, whereas DENV-2 was firstly isolated
in January 2008 and became the predominant serotype
since then (data not shown).
The most frequent clinical features in dengue patients
were exhaustion (98.6%), myalgia (92.8%), and headache
(87.0%). However, these features were also very prevalent
among ND patients and were useless for discriminating
between D and ND patients. From clinical history, only
taste disorder (OR: 2.15; IC95%:1.06–4.36) and the re-
port of rash (OR: 3.33; IC95%: 1.56–7.07) were asso-
ciated with dengue diagnosis. Bitter taste and diminished
taste were the most frequently reported taste disorders.
On physical examination, rash, lymph node enlargement,
and conjunctival redness were significantly more fre-
quent in D patients than in ND patients (Table 2). Con-
sidering laboratory results, platelet and leukocyte counts
were significantly smaller in the D than in the ND group
(Table 3).
The variables that were significantly associated with
dengue diagnosis in the univariate analysis were selected
for inclusion in multiple regression models. These mod-
els were based on data from 97 patients (52 D and 45
ND) as the others had incomplete data for one or more
of the selected covariates. The results of multiple regres-
sion analyses are presented in Table 4. In the model in-
cluding clinical data only (Model 1), conjunctival
redness and history of rash were the variables independ-
ently associated with the diagnosis. At the best cut-off
value, it showed an 84.6% sensitivity and 66.7% specifi-
city. According to the model equation, this accuracy is
achieved when we classify patients with conjunctival
redness or exanthema as D and those with neither of
these features as ND.
In the logistic regression with clinical and laboratory
data, only conjunctival redness and leukocyte count
showed to be independently associated with the diag-
nosis and were selected to remain in the final model
(Model 2). This model showed an AUC ROC of 0.82
Table 1 Characteristics of the sample according to
diagnosis of dengue or non-dengue
Dengue Non-dengue p value a
(N = 69) (N = 73)
Sex, n (%)
Male 45 (65.2) 35 (47.9) 0.028
Female 24 (34.8) 38 (52.1)
Age in years, median (IR) 31.0 (23–41) 33.2 (24–39) NS
Period, n (%)
Epidemic 49 (71.0) 37 (50.7) 0.010
Endemic 20 (29.0) 36 (49.3)
Health unit, n (%)
IPEC 62 (89.9) 62 (84.9) NS
HMLJ 7 (10.1) 11 (15.1)
NOTE. – a Chi-square test for categorical variables and Mann-Whitney test for
continuous variables; IR = Interquartile range.
Table 2 Clinical features associated to dengue diagnosis
in patients evaluated up to 3 days after fever onset
Clinical data Dengue Non-dengue OR (95% CI)
N % N %
History:
Exhaustion 68 98.6 69 95.8
Myalgia 64 92.8 67 93.1
Headache 60 87.0 64 87.7
Lumbar pain 59 85.5 59 81.9
Anorexia 55 79.7 55 75.3
Retro-orbital pain 49 71.0 44 60.3
Taste disorder 47 70.1 36 52.2 2.15 (1.06–4.36)
Nausea 45 65.2 40 54.8
Arthralgia 44 63.8 43 58.9
Photophobia 38 55.9 35 47.9
Chills 33 47.8 42 57.5
Dizziness 33 47.8 34 46.6
History of rash 30 44.1 14 19.2 3.33 (1.56–7.07)
Cough 25 36.2 26 35.6
Diarrhea 25 36.2 18 24.7
Vomiting 22 31.9 17 23.6
Itching 21 31.3 13 18.6
Abdominal pain 21 30.4 31 42.5
Coryza 20 29.0 21 28.8
Sore throat 16 23.2 27 37.0
Nasal congestion 14 20.9 17 24.6
History of bleeding 12 17.4 6 8.2
Earache 11 16.2 5 6.9
Hoarseness 11 16.2 9 12.5
Dyspnea 10 14.5 7 9.7
Physical exam:
Rash 48 71.6 31 45.6 3.02 (1.48–6.16)
Conjunctival redness 38 55.9 20 29.0 3.10 (1.53–6.29)
Lymph node enlargement 33 50.8 14 20.6 3.98 (1.86–8.53)
Dehydration 24 35.3 16 23.2
Pharyngeal erythema 15 22.4 21 31.3
Pallor 11 16.4 15 21.7
Petechiae 9 13.4 4 5.9
Hepatomegaly 7 10.4 5 7.4
Splenomegaly 5 7.5 5 7.2
Crude odds ratios (OR) and respective 95% confidence intervals (CI) are shown
for those with statistical significance.
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with 80.8% sensitivity and 71.1% specificity at the best
cut-off value. Adjusted odds ratios for each model vari-
able are shown on Table 4. WHO criterion for probable
dengue—the presence of two out of seven features—
showed 98.0% sensitivity but only 4.4% specificity. The
ROC curve for the WHO criteria showed an AUC of
0.71, which was significantly smaller than that of Model
2 (p = 0.04) (Figure 1).
Replacing the best cut-off value in the Model 2 equa-
tion, we found two combinations of variable values
that would indicate a dengue diagnosis in this setting:
1) conjunctival redness in a patient with a leukocyte
count below 7,500/mm3; or 2) leukocyte counts below
3,760/mm3 independently of other features.
Discussion
Dengue is one of the most underreported tropical dis-
eases [1]. On the other hand, during epidemics, overre-
porting can occur at some health sites. The lack of
laboratory resources and the nonspecific clinical presen-
tation of non-severe cases greatly contribute to this situ-
ation [36]. Diagnostic algorithms based on clinical data
may enhance disease diagnosis and surveillance in en-
demic areas.
Table 3 Clinical signs and hematologic parameters
according to definite diagnosis (dengue or non-dengue)
Median (IR) p value a
Dengue Non-dengue
Axillary temperature (°C) 37.1 37 NS
(36.5–38.2) (36.5– 37.8)
Heart rate 84 80 NS
(78.0–90.0) (72.0–91.0)
Respiratory rate 19 19 NS
(16.0–20.0) (16.0–20.0)
MAP sitting (mmHg) 92.5 88.3 NS
(83.3–100.0) (77.5–96.7)
MAP recumbent (mmHg) 93.3 93.3 NS
(83.3–102.5) (83.3–97.9)
Hematocrit (%) 42 42.3 NS
(39.3–45.0) (40.0–45.1)
Platelets (1000/mm3) 175 209 0.002
(121.5–218.0) (171.0–237.5)
Hemoglobin (g/dl) 14.4 14.2 NS
(13.2–15.3) (13.6–15.3)
Leukocytes (/mm3) 3600 6205 < 0.001
(2745–5015) (4248–8718)
NOTE. – IR = Interquartile range. a Non-parametric Mann-Whitney test.
MAP =Mean arterial pressure.
Table 4 Adjusted odds ratios and accuracy parameters for dengue diagnosis of multiple logistic regression models
according to the range of included data (clinical only or clinical and laboratory)
Adjusted diagnostic odds ratio Sensitivity Specificity
OR 95% CI % 95% CI % 95% CI
Model 1 - Clinical data only
History of Rash 3.84 1.54–10.24 84.6 46.8–93.0 66.7 38.6–78.8
Conjunctival redness 4.05 1.69–10.31
Model 2 - Clinical and laboratory data
Conjunctival redness 4.1 1.61–11.22 80.8 59.6–94.6 71.1 53.3–84.4
Leukocytes (ln)a 0.13 0.04–0.34
NOTE. – OR: odds ratio; 95% CI: 95% confidence interval. a Effect for each unit of natural logarithm of leukocyte count.
Figure 1 Receiver-operating characteristic (ROC) curves for the
logistic model with clinical and laboratory data (Logistic) and
for the WHO criteria for probable dengue (WHO). Sensitivity
and specificity at the best cut-off points for the models with clinical
and laboratory data (●) and clinical data only (▲). ROC Curves
(Area; 95% CI)_____ Logistic (0.82; 0.73–0.90); _ _ _ _
WHO (0.71; 0.61–0.81).
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In this study, we identified some clinical and
hematological features associated to confirmed dengue
cases. We also constructed simple predictive models for
dengue diagnosis based on clinical and hematological
data for patients presenting early in the course of dis-
ease. These models showed moderate accuracy [37], and
performed better than the diagnostic features proposed
by WHO for probable dengue [30] in the study
population.
Among clinical features, rash, taste disorder, conjunc-
tival redness, and lymph node enlargement were all
associated with dengue diagnosis. Rash is among the
classic signs of dengue fever and its description includes
different cutaneous manifestations, such as a diffuse ery-
thema coincident with fever or a macular exanthema
that is more frequent after the third day of disease [1,6].
Rash has also been reported to be more common in pri-
mary than in secondary infections [38], an issue that we
could not explore in our study.
The extraordinarily high prevalence of rash detected
on the physical exam of dengue patients (72%) in our
study can be related to major efforts to ascertain any
kind of cutaneous manifestations in a research setting.
These may have included a mild flushing that would
otherwise be unnoticed. It should be noted that a history
of rash was more accurate for dengue diagnosis than its
detection on physical exam. The same finding was also
reported by Chadwick et al. [17] who found that history
of rash was the only independent clinical predictor that
remained in a regression model which included clinical
and laboratory data. In this context, the possibility that
self-examination could be more accurate than medical
examination at ascertaining some mild cutaneous mani-
festation should be considered.
Comparing our results with other reports, we found
that taste alteration, conjunctival redness, and lymph-
adenopathy, although described as common manifesta-
tions of dengue fever [1], are not consistently
investigated as predictive signs and symptoms in studies
on dengue diagnosis [14]. Nevertheless, taste alteration
was reported as a dengue predictor by the few research-
ers who investigated this symptom [15,39], and conjunc-
tival redness was reported by Low et al. [15] as one of
the most accurate signs (p < 0.0005; OR = 4.49) for den-
gue diagnosis among adult outpatients with a fever last-
ing less than 72 hours. The frequency of lymph node
enlargement in dengue patients has varied from 3% [14]
to about 20% [17,23] in studies that reported this sign.
In these studies, it was not a useful sign to discriminate
D from ND patients, despite being more frequent among
the first ones in all of them.
The importance of ocular findings warrants better in-
vestigation as recent studies have described a variety of
ocular manifestations in dengue [40-42], suggesting that
eye involvement may be more common than usually
appreciated. Gregory et al. (2010) also highlighted the
importance of ocular manifestations in dengue as they
found retro-orbital pain as an important clinical feature
to discriminate dengue from OFI in all age groups [20].
Among hematological data, leukocyte count was the
most discriminant feature. Although common in other viral
illness, leukopenia has been consistently reported as an in-
dependent predictor of dengue diagnosis among febrile
patients [14,16,19], particularly in adults [19,20,43-46], and
seems to occur earlier than thrombocytopenia [43,44]. In-
deed, it was the most important isolated predictor in our
study.
Other authors have already proposed models and
scales to predict dengue infection in febrile adults living
in the Americas. Comparison between predictive rules
and WHO criteria through ROC curve analysis was also
done by some of them. In Colombia, Díaz et al. (2006)
developed a scale which performed better as an early
predictor in adults than the one produced with WHO
criteria (AUC ROC of 81.0% versus 70.0%). It was com-
posed by the presence of rash, positive tourniquet test,
absence of nasal discharge, arthralgias, absence of diarrhea
(1 point for each finding), leukocyte count <4,000/mm3
(3 points) and platelet count <180.000/mm3 (2 points)
[19]. Similar accuracy was obtained in Puerto Rico with
a predictive model for adults with suspected dengue
(AUC ROC: 79.7%). Retro-orbital pain, rash, absence of
sore throat, and leukopenia were the independent pre-
dictors in this age group [20].
As strengths of this study, we may cite the collection
of clinical data by a trained team, before the perform-
ance of laboratory tests, and the use of a comprehensive
standardized protocol for history taking and examin-
ation. The recording of clinical features prior to any test
result minimized the risk of observation bias, and the in-
clusion of clinical features other than the usual dengue
signs and symptoms allowed us to identify some poten-
tially useful new predictors.
This study also has some limitations. The first one is
related to the small sample size used in multiple regres-
sion analysis. This may be attributed in part to the char-
acteristics of our clinic, which attends mainly referred
patients, to a long period without epidemics when we
had slow subject enrollment and to our option to
analyze only data from patients in the first three days of
disease. The small sample size precluded any subgroup
analyses.
We also had considerable losses because of indeter-
minate diagnosis (40/182), as only 66 out of 182 (36.3%)
eligible patients collected two blood samples. Although
the use of NS1 test helped to diagnose dengue in
patients with samples collected from day 0 to day 2,
those with only one negative sample collected between
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day 3 and day 7 were classified as indeterminate, as a
negative result in both IgM and NS1 could be a false-
negative by this time. As a consequence, we had rela-
tively few confirmed ND patients. This kind of problem,
however, affects most studies with outpatients, in such a
way that losses greater than 30% for indeterminate diag-
noses are common in this setting [20,47].
We cannot exclude the possibility of some misclassifi-
cation by our reference standard in dengue diagnosis.
Although sensitivities above 90% for NS1 on days 0 to 2
[26,48] and sensitivities above 93% for IgM in samples
collected after the seventh day of disease have been
reported in patients with a primary infection [1,28,49],
both tests have lower sensitivities in secondary infections
[28,50]. As dengue is endemic in Rio de Janeiro, it is
possible that some dengue patients have been classified
as non-dengue. The consequence of this eventual mis-
classification would be a decrease in the measured odds
ratios with underestimation of the accuracy of analyzed
predictors.
The interpretation and generalization of the results of
studies such as this one must consider the fact that diag-
nostic accuracy of clinical manifestations also depends on
their frequency in the non-dengue group. This means that
it varies according to the incidence of other febrile ill-
nesses (OFI) in the same period and place. For instance,
low platelet counts may be useless to discriminate dengue
from OFI in a place where malaria is endemic, as low
platelet counts are also frequent in the later [17]. In our
study, laboratory tests for OFI were required as indicated
by clinical suspicion and we are unable to describe the
prevalence of other diagnoses, except for malaria, which
was rare (2%) in the study population.
Although our model outperformed the diagnostic ac-
curacy of the WHO criteria, its predictive value is still
poor, with some 20% false negative among dengue
patients and 30% false positive among those with OFI.
The low accuracy of WHO case definition, mainly be-
cause of its low specificity has been described by Martinez
et al. (2005), who also explored the accuracy of different
number of WHO criteria [51]. The difficulty to identify
early clinical predictors of dengue infection in adults has
been described by Ramos et al. (2009) in a large study in
Puerto Rico. Although they identified eye pain, diarrhea
and absence of upper respiratory symptoms as indepen-
dently associated to confirmed dengue cases, they also
highlighted the low predictive value of these features,
alone or in combination, for early infection in adults
[18]. In spite of this relatively low accuracy, the use of
management protocols based on clinical diagnostic scales
proved useful to reduce hospitalizations due to dengue in
Colombia [52].
Nonetheless, the results of this study are potentially
helpful for surveillance in adults, as they suggest that the
proposed criteria, derived from simple clinical and
hematological data, can be more accurate than the cri-
teria for reporting suspected dengue cases currently in
use. The use of this alternative algorithm could enhance
the ascertainment of dengue cases by clinical and epi-
demiological criteria, and enable a more accurate esti-
mation of the disease burden. Meanwhile, it should be
stressed that in endemic areas, while early accurate la-
boratory tests are not widely available, dengue fever
should be considered in every patient presenting with an
acute undifferentiated febrile illness. Monitoring all
these patients for the development of signs of severity,
however, may impose a great burden on the health ser-
vices. Once validated, algorithms that enable early iden-
tification of dengue cases could influence clinical
outcomes as they would allow closely monitoring of
selected patients. This procedure may warrant timely
identification of alarm signs and the adoption of simple
and widely available therapeutic support measures that
are effective in preventing fatalities [7].
Conclusions
We constructed predictive models for early dengue diag-
nosis that were moderately accurate and performed bet-
ter than the diagnostic features proposed by WHO for
dengue surveillance.
Considering only clinical features, the presence of con-
junctival redness or a history of skin rash, in contrast
with the absence of these features, showed 84.6% sensi-
tivity and 66.7% specificity for dengue diagnosis. Con-
junctival redness in a patient with a leukocyte count
below 7,500/mm3 or leukocyte counts below 3,760/mm3
independently of other features showed an 80.8% sensi-
tivity and 71.1% specificity.
These results can be useful for the development of
predictive clinical tools as they may call attention to
signs that are frequently ignored on dengue research.
Validation of the proposed predictive model in larger
datasets is advisable before using it for clinical or sur-
veillance purposes. Studies with large sample sizes are
also needed to identify and confirm predictors of dengue
infection in different epidemiological contexts.
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